You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 8, August 25, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (88)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rifampin Therapy of Staphylococcus epidermidis

Use in Infections From Indwelling Artificial Devices

Gordon L. Archer, MD; Marvin J. Tenenbaum, MD; Hubert B. Haywood III, MD

JAMA. 1978;240(8):751-753.


Abstract

Rifampin was added to existing antibiotic regimens in two patients with Staphylococcus epidermidis infections; one patient had prosthetic valve endocarditis and the other had an infection of a CSF shunt. The addition of rifampin increased serum or CSF bactericidal titers 16-fold or greater and was correlated with a favorable clinical response. The results of tests for tube-dilution antibiotic susceptibility showed rifampin to be the most active of all antibiotics tested against the patients' organisms. The combinations of gentamicin sulfate, nafcillin sodium, or vancomycin hydrochloride with rifampin prevented the emergence of rifampin resistance in vitro and promoted enhanced killing when compared with either antibiotic alone.

(JAMA 240:751-753, 1978)



Author Affiliations

From the Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond.


Footnotes

Reprint requests to Division of Infectious Diseases, Medical College of Virginia, Box 92, Richmond, VA 23298 (Dr Archer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study
Chu et al.
Heart 2009;95:570-576.
ABSTRACT | FULL TEXT  

Thrombotic and Infectious Complications of Hickman-Broviac Catheters
Jacobs and Yeager
Arch Intern Med 1984;144:1597-1599.
ABSTRACT  

Staphylococcus epidermidis Causing Prosthetic Valve Endocarditis: Microbiologic and Clinical Observations as Guides to Therapy
KARCHMER et al.
ANN INTERN MED 1983;98:447-455.
ABSTRACT  

Coagulase-Negative Staphylococcal Bacteremia in Patients Receiving Immunosuppressive Therapy
Winston et al.
Arch Intern Med 1983;143:32-36.
ABSTRACT  

Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with Granulocytopenia
WADE et al.
ANN INTERN MED 1982;97:503-508.
ABSTRACT  

Rifampin and Cefazolin as Prophylactic Agents: A Comparison in an Animal Model of Vascular Graft Infection
Rutledge et al.
Arch Surg 1982;117:1164-1165.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.